American Rare Earths Achieves Recognition in 2025 OTCQX Best 50 Ranking
American Rare Earths (ASX: ARR, OTCQX: ARRNF, ADR: AMRRY) has been recognized in the 2025 OTCQX Best 50, a prestigious list that highlights the top-performing
Home
Page 2
BTQ Technologies Expands Quantum Security Capabilities with Cimtech Acquisition
BTQ Technologies Corp. (CBOE CA: BTQ, FSE: NG3, OTCQX: BTQQF), a prominent player in the quantum technology sector, has made a significant leap forward by
Andean Precious Metals Secures Agreement to Purchase up to 100,000 Tonnes of Oxide Material
Andean Precious Metals Corp. (TSX: APM, OTCQX: ANPMF) has taken a significant step in enhancing its operational capabilities by entering into an exclusive Sale and
Glass House Brands Recognized Among 2025 OTCQX Best 50 for Second Consecutive Year
Glass House Brands Inc. (CBOE CA: GLAS.A.U, OTCQX: GLASF), a leading vertically-integrated cannabis company in the United States, has achieved notable recognition by being named
Lion One Metals Achieves Record Gold Sales and Revenue in Q4 2024
Lion One Metals Limited (TSXV: LIO, OTCQX: LOMLF), a Canadian gold producer based in North Vancouver, has reported impressive financial results for the fourth quarter
Review of BioLargo’s 2024 Achievements and Outlook for 2025
BioLargo, Inc. (OTCQX:BLGO), recognized for the creation of innovative sustainable technologies, has announced a comprehensive review of its performance in 2024 along with an ambitious
WTI Crude Oil Prices Surge Amid New Sanctions on Russia
The recent fluctuations in WTI crude oil prices have captured the attention of investors and analysts alike. After starting at $67.10 per barrel on December
Barrick Gold Halts Operations in Mali Following Government Seizure of Gold Reserves
In a significant escalation of tensions between Barrick Gold (NYSE: GOLD, TSE: ABX) and the Malian government, the Canadian mining giant has temporarily suspended operations
Calidi Biotherapeutics to Showcase Innovative Systemic Virotherapy Data at AACR 2025
Calidi Biotherapeutics Inc. (NYSE American: CLDI), a clinical-stage biotechnology firm focused on developing advanced antitumor virotherapies, has announced that its research abstract titled “Development of
American Business Bank Initiates Stock Repurchase Program
American Business Bank (OTCQX: AMBZ) has taken a significant step in managing its capital structure by announcing a stock repurchase program, marking its first such
